NeutriSci International Inc.
NRXCF · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -8.7% | -3.4% | -94% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 62.1% | 77.5% | 65.2% | -63.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,430.4% | -4,643.1% | -3,631.8% | -312.7% |
| Other Income/Exp. Net | -$0 | $0 | $0 | $0 |
| Pre-Tax Income | -$0 | -$0 | -$0 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,563.5% | -4,620.1% | -3,213% | -425.5% |
| EPS | -0.001 | -0.001 | -0.001 | -0.001 |
| % Growth | 37.5% | -33.3% | 50% | – |
| EPS Diluted | -0.001 | -0.001 | -0.001 | -0.001 |
| Weighted Avg Shares Out | 178 | 178 | 178 | 176 |
| Weighted Avg Shares Out Dil | 178 | 178 | 178 | 176 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,236.2% | -4,329.9% | -3,380.1% | -407.3% |